NASDAQ
Revelation Biosciences, Inc. (REVB) has a current ratio of 5.41x as of Tuesday, May 26, 2026. This represents a 180.25% increase compared to its 12-month average of 1.93x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.